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Mouse geneticsHeart development requires contributions from, and coordinated signaling interactions between, several cell
populations, including splanchnic and pharyngeal mesoderm, postotic neural crest and the proepicardium.
Here we report that Fgf3 and Fgf10, which are expressed dynamically in and near these cardiovascular
progenitors, have redundant and dosage sensitive requirements in multiple aspects of early murine
cardiovascular development. Embryos with Fgf3−/+;Fgf10−/−, Fgf3−/−;Fgf10−/+ and Fgf3−/−;Fgf10−/−
genotypes formed an allelic series of increasing severity with respect to embryonic survival, with double
mutants dead by E11.5. Morphologic analysis of embryos with three mutant alleles at E11.5–E13.5 and double
mutants at E9.5–E11.0 revealed multiple cardiovascular defects affecting the outﬂow tract, ventricular
septum, atrioventricular cushions, ventricular myocardium, dorsal mesenchymal protrusion, pulmonary
arteries, epicardium and fourth pharyngeal arch artery. Assessment of molecular markers in E8.0–E10.5
double mutants revealed abnormalities in each progenitor population, and suggests that Fgf3 and Fgf10 are
not required for speciﬁcation of cardiovascular progenitors, but rather for their normal developmental
coordination. These results imply that coding or regulatory mutations in FGF3 or FGF10 could contribute to
human congenital heart defects.netics, University of Utah, 15 N
ax: +1 801 581 7796.
L. Mansour).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Development of the heart and great vessels requires a highly
choreographed interplay of multipotent progenitor cell populations.
Interference with the progenitors, or with their intercellular in-
teractions, leads to congenital heart defects (CHDs), which affect
nearly 1% of live births (Bruneau, 2008). The primitive heart tube
forms by ventral fusion of dorsally connected, bilaterally situated
wings of splanchnic mesoderm referred to as the ﬁrst heart ﬁeld
(FHF). These cells contribute most of the myocardium and endocar-
dium of the primitive left ventricle, and a small proportion of the cells
in the right ventricle and atria. Subsequent addition of a second
mesodermal cell population, located dorsal andmedial to the FHF, and
termed the second heart ﬁeld (SHF), lengthens the heart tube from
both the anterior (outﬂow, or arterial) and posterior (inﬂow or
venous) poles. The SHF is the major contributor of myocardium and
endocardium to the outﬂow tract (OFT), the right ventricle, and dorsal
mesenchymal protrusion (DMP), as well as to a majority of the atria
and a portion of the inﬂow tract (IFT) (Abu-Issa and Kirby, 2007;Chien et al., 2008; Snarr et al., 2008). Developmental abnormalities of
these mesodermal cells can lead to a variety of cardiac defects,
depending on the timing of perturbation. Early perturbations can
disrupt heart tube looping, ventricular growth or myocardial cell
differentiation. Dysfunction of the SHF causes a spectrum of cardiac
malformations affecting the arterial pole and OFT, including tetralogy
of Fallot, double outlet right ventricle and persistent truncus
arteriosus (PTA) (Moon, 2008; Vincent and Buckingham, 2010;
Ward et al., 2005). SHF defects also cause malformations of the IFT,
including atrioventricular (AV) septal and sinus venosus defects, as
well as anomalous pulmonary venous return (Bleyl et al., 2010;
Goddeeris et al., 2008; Mommersteeg et al., 2010).
Higher vertebrate OFT development depends not only on cells
contributed by the SHF, but also on the cardiac neural crest (CNC),
which originates from the dorsal hindbrain, posterior to the otic
vesicle (rhombomeres (r)6–8). CNC cells undergo an epithelial-to-
mesenchymal transition (EMT), and then migrate ventrally through
pharyngeal arches 3, 4 and 6, and into the OFT. CNC contributes
relatively few cells to the mature heart proper—the CNC lineage is
found mainly in the smooth muscle of the great arteries, the
aorticopulmonary septum and the cardiac ganglia. However, CNC
interactions with the SHF and its derivatives play critical roles in
cardiovascular development, supporting the deployment of SHF cells
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development can cause the same spectrum of defects as seen with
abnormal SHF function (Bruneau, 2008; Kirby and Hutson, 2010;
Snider et al., 2007).
Another source of cardiac cells is the proepicardial organ (PEO),
which forms in the mesothelium just posterior to the developing
heart, at the anterior surface of the septum transversum. Proepicardial
cells migrate over the surface of the heart, forming the epicardium; a
thin layer of cells covering the heart. Some epicardial cells undergo an
EMT, enter the heart proper, and generate the smooth muscle of the
coronary vasculature and the heart ﬁbroblasts. The epicardium also
provides signals supporting ventricular myocardial growth (Carmona
et al., 2010; Gittenberger-de Groot et al., 2010; Ratajska et al., 2008).
Whether the PEO comprises a subpopulation of the SHF or is a
completely independent contributor is unclear. The latest lineage
tracing data suggest that the proepicardium and SHF myocardial
contributors to the IFT have a common origin (van Wijk et al., 2009).
Thus, defects occurring in the epicardial lineage, after separation from
the posterior SHF, affect the developing coronary vasculature and
induction of the ventricular compact myocardium and interstitial
ﬁbroblast network. Defects arising prior to the lineage separation,
may affect both the IFT and the epicardium (Mommersteeg et al.,
2010).
Fibroblast Growth Factors (FGFs) are among the critical signals
controlling communication within and between developing heart
progenitors. The secreted FGFs comprise an 18-member ligand family
that signals through seven major receptor tyrosine kinase isoforms
encoded by four genes (Itoh and Ornitz, 2008). FGF8 is the best
understood of these signals regulating cardiovascular development.
Very early expression of Fgf8, presumably in the vicinity of the node,
controls left–right axis formation, and thus normal looping of the
heart tube (Meyers and Martin, 1999). Later expression of Fgf8 in the
SHF mesoderm is required for expansion of the anterior heart tube
and normal OFT alignment (Brown et al., 2004; Ilagan et al., 2006;
Park et al., 2006). Expression in the pharyngeal ectoderm is required
for normal aortic arch artery development (Macatee et al., 2003; Park
et al., 2006). Although ablation of Fgf8 from the pharyngeal endoderm
alone does not disrupt OFT development, combined Fgf8 ablation from
endoderm and the SHF causes PTA in 100% of mutants (Park et al.,
2006), phenocopying CNC ablation in chick (Kirby et al., 1985).
However, the effects of FGF8 on neural crest are likely indirect, as
conditional neural crest-speciﬁc deletion of Fgfr1 and Fgfr2, or indeed
the FGF downstream signaling pathway coordinated by Frs2α, has no
effect on heart development (Park et al., 2008; Zhang et al., 2008).
Fgf15 is also required for normal OFT alignment and for ventricular
septation (Vincentz et al., 2005). Defective CNC invasion of the OFT
cushions in Fgf15 null embryos is proposed as the mechanism
underlying the mutant phenotypes, but the relationship between
these defects and the function of FGF15, derived from the pharyngeal
endoderm, ectoderm, and neurectoderm adjacent to the developing
neural crest (Vincentz et al., 2005; Wright et al., 2004), has not yet
been investigated.
Fgf10, which is expressed prominently in the SHF (Kelly et al.,
2001), does not by itself have a major function in heart development.
Fgf10 null embryos, which die at birth due to lung aplasia, also lack
pulmonary arteries and veins and have heartswith a slightly abnormal
position within the thoracic cavity (Marguerie et al., 2006). However,
Fgf10 is strongly implicated in heart development because it interacts
genetically with Fgf8. The penetrance of pharyngeal arch artery 4
(PAA4) and OFT defects is increased in FHF/SHF conditional Fgf8
mutants by removal of Fgf10 alleles (Watanabe et al., 2010).
Furthermore, ablation of the major FGF10 receptor, FGFR2b, causes
more severe heart abnormalities than ablation of Fgf10, including
ventricular septal defect (VSD) and delayed OFT septation, leading to
alignment defects, and thin and poorly trabeculated ventricles
(Marguerie et al., 2006). This suggests that other FGFR2b ligands (i.e.FGF3, FGF7, or FGF22)might be functionally redundant with FGF10 for
some aspects of cardiovascular development.
Here we report that Fgf3 and Fgf10 have redundant and dosage
sensitive requirements in multiple aspects of early cardiovascular
development. Embryos with Fgf3−/+;Fgf10−/−, Fgf3−/−;Fgf10−/+ and
Fgf3−/−;Fgf10−/− genotypes formed an allelic series of increasing
severity with respect to embryonic survival, with double mutants dead
by E11.5. Morphologic analysis of triple-allelic mutants (Fgf3−/+;
Fgf10−/− and Fgf3−/−;Fgf10−/+) at E11.5–E13.5 and double mutants
(Fgf3−/−;Fgf10−/−) at E9.5–E11.0 revealed multiple cardiovascular
defects affecting the OFT, ventricular septum, AV cushions, ventricular
myocardium, DMP, pulmonary arteries, epicardium and PAA4.
Molecular marker studies of double mutants revealed abnormalities
in each cardiac progenitor cell population. There were reduced
streams of postotic neural crest and strikingly, expression of Isl1,
encoding a critical SHF transcription factor, was transiently decreased
in the double mutant SHF at E8.5, whereas Nkx2-5 expression in
cardiomyocytes was not affected until E10.5, and Fgf8 and Fgf15were
never affected. In addition, epicardial markers were reduced in double
mutants by E10.5. We propose that the double mutant cardiovascular
defects are caused by loss of redundant, dosage sensitive FGF3 and
FGF10 signals that act directly on the SHF and its derivatives, and
indirectly on the CNC to coordinate their development. In addition,
our results support a very early role for these FGFs in epicardial/
myocardial interactions. Finally, we suggest FGF3 and FGF10 as
candidate genes contributing to human CHDs.
Materials and methods
Mutant mice and genotyping
All mouse studies complied with protocols approved by the
University of Utah Institutional Animal Care and Use Committee. The
original double heterozygous intercross involving Fgf3neo (Fgf3tm1Mrc;
MGI:1931059) and Fgf10neo (Fgf10tm1Wss; MGI:1927833) null alleles
and their genotyping were described in Wright and Mansour (2003).
The newer Fgf3 and Fgf10 conditional (Fgf3tm1.2Sms; MGI:4456396 and
Fgf10tm1.2Sms; MGI:4456398, each abbreviated “c”) and null alleles
(Fgf3tm1.1Sms; MGI:3767558 and Fgf10tm1.1Sms; MGI:3526181; each
abbreviated “Δ2” or “–”), the HprtCre allele (Hprttm1(cre)Mnn;
MGI:2181632), and genotyping protocols used in this study are
described in Urness et al. (2010). All progenitors used in crosses came
from a mixed genetic background primarily comprised of C57Bl/6 and
various 129 “S” and “P” substrains. Embryos were considered to be
E0.5 at noon on the day of mating plug detection.
Histology and three-dimensional reconstructions
E9.5 embryos were harvested in cold PBS and incubated in 50 μg/
ml of verapamil (Sigma V4629) in phosphate-buffered saline for 5–
10 min to relax the myocardium. Embryos were then ﬁxed in 4%
paraformaldehyde solution, followed by standard parafﬁn wax
embedding, transverse sectioning at 8 μm and hematoxylin and
eosin (H&E) staining. For three-dimensional visualization of E10.5
specimens and standard histologic preparation of E11.5 and E13.5
specimens, embryos were ﬁxed in Bouin's solution prior to wax
embedding. Transverse 8 μm sections were cut from the anterior end of
the pharyngeal arches to the ductus venosus and stained with H&E.
E10.5 serial stained sectionswere digitally imaged at 10×magniﬁcation.
Images were aligned, segmented and reconstructed using the Amira
software package version 5.0 (Visage Imaging, Inc., San Diego).
Immunohistochemistry and intravascular dye injection
Tuj1 immunohistochemistry (directed against neuronal class III
ß-tubulin) was performed according to Chisaka et al. (1992). Vascular
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common ventricle of E10.5 embryos harvested in PBS (yolk sacs
reﬂected, but not removed). The embryos were placed in Carnoy's
ﬁxative and photographed immediately following injection.In situ hybridization
Whole-mount non-radioactive in situ hybridization of embryos,
post-ﬁxation, cryoprotection and sectioning at 14 μm was performed
as described previously (Urness et al., 2010). Control and double
mutant embryos were developmentally matched to within 2 somites
and hybridized and developed in the same tubes for the same amount
of time. Cloned mouse cDNAs used to prepare digoxigenin-labeled
RNA probes included Fgf3 and Fgf10 (Wright and Mansour, 2003),
Fgf15 (Wright et al., 2004), Fgf8 (Ladher et al., 2005), Isl1 and Mef2c
(Park et al., 2006), Wnt1 and Bmp4 (Hatch et al., 2007), Sox9 (Urness
et al., 2010) and Tcf21 (Epicardin; GenBank accession NM_011545,
purchased from OpenBiosystems). Sox10, Tbx1, Tdgf1 (Cripto) and
Wnt11, Pax3, Hand2 (dHand), Tbx18, Cadh6, Nkx2-5 and Myl7 (Mlc2a)-
containing plasmids for probe preparation were kindly provided by
Drs. P. Koopman, B. Morrow, Y. Saijoh, G. Kardon, D. Guns, A. Kispert,
O. Chisaka, D. Li and S. Evans, respectively. RNA probes speciﬁc for the
3′UTR of Gata4 andWnt2awere generated by T7 polymerase-directed
transcription of DNA fragments generated by PCR-ampliﬁcation of
genomic DNA using a Gata4 forward primer, 5′-CAAGGAGGAA-
CAAAACCTGCTACC-3′ with a T7 promoter-tagged Gata4 reverse
primer, 5′-ggatcctaatacgactcactatagggagGACAAGGAAGAATCTCTGG-
GAGC-3′ and a Wnt2a forward primer, 5′-TTTTCCCAGATTCCAA-
CAACCC-3′ with a T7 promoter-tagged Wnt2a reverse primer, 5′-
ggatcctaatacgactcactatagggagCCATTCCCCTTTCAGATTCTCTCC-3′ as
described by Urness et al. (2010). Note that the Fgf10Δ2 transcript,
which has a premature termination codon rendering it unable to
produce FGF10, is stable (RT-PCR data not shown) and can be detected
in Fgf10Δ2/Δ2 mutant embryos by in situ hybridization using our
standard probe.Table 1A
The Fgf3−/−;Fgf10−/− genotype is lethal after E11.0. Fgf3neo/+;Fgf10neo/+ animals were interc
to Fgf3c/c;Fgf10c/c males (Table 1B) and embryos were genotyped at the indicated ages. Bot
embryos of each genotype is indicated together with the expected number in parentheses. Al
E11.5–15.5 did not ﬁt theMendelian expectation, due to lethality of the double mutant class a
E8.5–E11.0 double heterozygote intercross totals shown in Table 1Awere previously reporte
of Fgf3−/+;Fgf10−/+ intercross offspring.
Age Total # Fgf3+/+
Fgf10+/+
Fgf3−/+
Fgf10+/+
Fgf3−/−
Fgf10+/+
Fgf3+/
Fgf10−
E8.5−E11.0 1878
(exp.)
127
(117)
237
(235)
122
(117)
212
(235)
E11.5–E15.5 267
(exp.)
27
(17)
46
(33)
14(1⁎)
(17)
37
(33)
Table 1B
The Fgf3−/−;Fgf10−/− genotype is lethal after E11.0. Fgf3neo/+;Fgf10neo/+ animals were interc
to Fgf3c/c;Fgf10c/c males (Table 1B) and embryos were genotyped at the indicated ages. Bot
embryos of each genotype is indicated together with the expected number in parenthes
Genotypes at E11.5–15.5 did not ﬁt the Mendelian expectation, due to lethality of the double
included in the E8.5–E11.0 double heterozygote intercross totals shown in Table 1A were pr
2003). Genotypes of Fgf3−/+;Fgf10−/+;HprtCre/+×Fgf3c/c;Fgf10c/c offspring.
Age Total # Fgf3−/+
Fgf10−/+
b40 somites 814
(exp.)
197
(203.5)
≥40 somites 24
(exp.)
10
(6)
⁎ Dead/necrosing embryos.Results
Fgf3 and Fgf10 are required for viability after E11.0
Our previous studies of Fgf3 and Fgf10 in inner ear development
revealed that although Fgf3−/− or Fgf10−/− mutant embryos were
recovered alive and in the expected numbers through E18.5, live
Fgf3−/−;Fgf10−/− embryos (Fgf3/Fgf10 double null mutants) were not
observed after E10.5 (Hatch et al., 2007; Mansour et al., 1993; Wright
and Mansour, 2003; T.J.W., L.D.U. and S.L.M., unpublished observa-
tions). To assess potential redundant roles for Fgf3 and Fgf10 in
viability, we intercrossed Fgf3−/+;Fgf10−/+ mice and observed and
genotyped offspring between E8.5 and E15.5 (Table 1A). Between E8.5
and E11.0, embryos of all possible genotypes were found alive in the
expected numbers. Of 267 embryos collected between E11.5 and
E15.5, all 8 Fgf3−/−;Fgf10−/− individuals (~50% of expected number)
were dead and resorbing. The recovery of embryos carrying a total of
three null alleles was reduced to ~67% of expected, but all other
genotypes were recovered at or above the expected number. The few
other dead/resorbing embryoswere either Fgf3−/− or Fgf3−/−;Fgf10−/
+. To generate double null mutants at a higher frequency, we mated
Fgf3Δ2/+;Fgf10Δ2/+;HprtCre/+ females with Fgf3c/c;Fgf10c/c males (dou-
ble mutants expected at 25% vs. 6.25% from the double heterozygous
intercross; Urness et al., 2010). Similar to the double heterozygote
intercrosses, live double null mutants of less than 40 somites (~E11.0)
could be obtained in the expected numbers; however, double null
mutants of greater than 40 somites were not recovered, and Fgf3−/−;
Fgf10−/+ embryos were dead or dying at this stage (Table 1B). These
data show that Fgf3 and Fgf10 are required for viability past E11.0, and
that the requirements for these genes are not equivalent, with Fgf3
more important for survival than Fgf10.
Heart development is sensitive to the dosage of both Fgf3 and Fgf10
Midgestational lethality can result from defective heart develop-
ment (Conway et al., 2003). To determine whether Fgf3 and Fgf10 playrossed (Table 1A) or, more recently, Fgf3Δ2/+;Fgf10Δ2/+;HprtCre/+ females were crossed
h the neo and Δ2 alleles are null and are designated as “–”in the table. The number of
l genotypes were recovered in the expected numbers between E8.5–E11.0. Genotypes at
nd reduced viability of Fgf3−/−;Fgf10−/+ embryos. Many of the embryos included in the
d and used in studies of inner ear development (Wright andMansour, 2003). Genotypes
+
/+
Fgf3−/+
Fgf10−/+
Fgf3−/−
Fgf10−/+
Fgf3+/+
Fgf10−/−
Fgf3−/+
Fgf10−/−
Fgf3−/−
Fgf10−/−
485
(470)
225
(235)
123
(117)
245
(235)
101
(117)
69
(67)
22(2⁎)
(33)
19
(17)
25
(33)
0(8⁎)
(17)
rossed (Table 1A) or, more recently, Fgf3Δ2/+;Fgf10Δ2/+;HprtCre/+ females were crossed
h the neo and Δ2 alleles are null and are designated as “–”in the table. The number of
es. All genotypes were recovered in the expected numbers between E8.5 and E11.0.
mutant class and reduced viability of Fgf3−/−;Fgf10−/+ embryos. Many of the embryos
eviously reported and used in studies of inner ear development (Wright and Mansour,
Fgf3−/−
Fgf10−/+
Fgf3−/+
Fgf10−/−
Fgf3−/−
Fgf10−/−
235
(203.5)
178
(203.5)
204
(203.5)
0(5⁎)
(6)
9
(6)
0
(6)
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carrying three mutant alleles, as these could be recovered as late as
E13.5, a time when many heart defects can be assessed. Examination
of H&E-stained transverse sections revealed a number of variably
penetrant anomalies in such embryos, affecting the OFT (Fig. 1), as
well as the AV septum, ventricular myocardium, epicardium and IFT
(Fig. 2).
At E13.5, we found persistent truncus arteriosus (PTA) and right
aortic arch (red arrow, Fig. 1C) in one of three Fgf3−/−;Fgf10−/+
embryos recovered for histology, but not in any of three Fgf3−/+;
Fgf10−/+ (control) embryos (Fig. 1A), nor in any of the single null
mutant (Fgf3−/− or Fgf10−/−; Figs. 1B and D) or Fgf3−/+;Fgf10−/−
(Fig. 1E) mutants examined. The other two Fgf3−/−;Fgf10−/+embryos
examined at this stage did not exhibit OFT defects and were likely rare
“escapers” that can survive later in gestation (Table 1A), or even to
birth (T.J.W. and S.L.M., unpublished data). At E12.5, OFT defects were
seen in both Fgf3−/−;Fgf10−/+ (Fig. 1H) and both Fgf3−/+;Fgf10−/−
(Fig. 1J) mutants examined. Embryos carrying three mutant alleles
had evidence of failure of rotation and alignment of the septating OFT
such that the aorta was completely committed to the right ventricle
(Figs. 1H and J) at a stage where there was clearly an LV outﬂow
connecting to the aorta in controls (Figs. 1F, G, and I; black arrows).
This would likely result in double outlet right ventricle were the
embryos to survive and continue OFT development. At E11.5, the OFT
of two of three Fgf3−/−;Fgf10−/+ embryos was completely occluded
with cells (Fig. 1M; red arrow) relative to embryos of all other
genotypes (Figs. 1K, L, N, and O). Since this phenotype is incompatible
with further survival, this may explain why OFT occlusion was not
observed at E12.5–E13.5. Together, these data reveal a previously
unappreciated role for Fgf3 and Fgf10 in OFT development, with
complete loss of Fgf3 and 50% reduction of Fgf10 resulting in more
penetrant and severe OFT defects than in the other triple-allelic
combination.
Moving posteriorly at E13.5, we found VSDs in both Fgf3−/−;
Fgf10−/+ and in two of four Fgf3−/+;Fgf10−/− embryos examined
(Figs. 2C and E; red arrows). Such defects were not described
previously in Fgf3−/− or Fgf10−/− embryos, however, in this genetic
background, we found VSDs in both E13.5 Fgf3−/−mutants examined
(Fig. 2C, red arrow), but not in control (n=4) or Fgf10−/− embryos
(Figs. 2A and D). A VSD was also observed in an Fgf3−/− embryo at
E14.5 (Suppl. Fig. 1), a time when such defects cannot be attributed to
variable development in different genetic backgrounds. VSDs might
therefore account for the reduced recovery of Fgf3−/− mutants at
weaning (Hatch et al., 2007; Mansour et al., 1993). In addition, the
E13.5 mid-heart sections (Figs. 2A–E), as well those prepared at E12.5
(Figs. 2F–J), and those illustrating the E11.5 OFT defect (Figs. 1K–O),
revealed that Fgf3−/−;Fgf10−/+ embryos had thin ventricular walls
and decreased trabeculae (Figs. 1M and 2C and H) relative to the other
genotypes.
At E12.5, we also found that Fgf3−/−;Fgf10−/+ embryos showed a
marked detachment of the epicardium from the underlying myocardi-
um (Figs. 2H and M; red arrows). Interestingly, the endocardium was
also only loosely associated with the myocardium (Fig. 2M; red caret).
Both Fgf3−/+;Fgf10−/−mutants (Figs. 2J and O) examined at this stage
also showed a degree of epicardial detachment, though not as extreme
as that observed in the Fgf3−/−;Fgf10−/+mutants. In contrast, Fgf3−/+;
Fgf10−/+ (Figs. 2F and K), Fgf3−/− (Figs. 2G and L) and the majority
(2/3) of Fgf10−/− hearts showed ﬁrmly adhered epicardia. However, it
was possible to ﬁnd areas of epicardial detachment in some regions of
one of the Fgf10−/− embryos (Figs. 2I and N).
Finally, E13.5 mutant embryos also showed both expected and
unexpected pulmonary vascular defects. As expected (Marguerie
et al., 2006), the pulmonary arteries were absent from both Fgf10−/−
and Fgf3−/+;Fgf10−/− embryos (Figs. 2S and T). We were surprised to
ﬁnd, however, that Fgf3−/−;Fgf10+/− embryos also lacked pulmonary
arteries (Fig. 2R), whereas they developed normally in control andFgf3−/− embryos (Figs. 2P and Q). Also as expected, the lungs failed to
form in Fgf10−/− and Fgf3−/+;Fgf10−/− embryos (Min et al., 1998;
Sekine et al., 1999), but unexpectedly, mildly hypoplastic lungs were
also observed in both Fgf3−/−;Fgf10+/− embryos (data not shown).
Taken together, these histologic results show that loss of an Fgf3
allele from the Fgf10 null background caused OFT alignment and
rotation defects, VSD and moderate epicardial detachment. Loss of an
Fgf10 allele from the Fgf3 null background also led to OFT alignment
and rotation defects and, in one case, PTA. These embryos also showed
VSD, thin and poorly trabeculated ventricular walls, severe epicardial
detachment, pulmonary artery aplasia and lung hypoplasia. Thus,
both Fgf3 and Fgf10 play previously unappreciated roles in heart and
lung development.
Fgf3/Fgf10 double null mutants display ﬁrst and second heart ﬁeld and
cardiac neural crest-related defects
To assess heart development in the complete absence of Fgf3 and
Fgf10, we examined double null mutants at E10.5–11.0, the oldest
stage that could be recovered reliably. As reported previously (Urness
et al., 2010; Wright and Mansour, 2003), double mutant embryos
lacked limbs and otic vesicles, and had short tails (Figs. 3A–C). In
addition, most live E10.5 double mutant embryos appeared slightly
smaller than Fgf3−/+;Fgf10−/+ littermate control embryos (Figs. 3A
and B), but some were much smaller than normal, and showed
pericardial effusion and chamber dilation, signs of cardiovascular
distress and imminent death (Fig. 3C). By E11.0, relative to Fgf3−/+;
Fgf10−/+ controls (Fig. 3D), the hearts of freshly dissected double
mutants beat very slowly or not at all, had severe blood pooling, and
the ventricleswere noticeably transparent (Fig. 3E). To avoid potential
artifact associated with developmental delay and possible necrosis, all
embryos analyzed in detail at this stage had the less severe phenotype
(as in Fig. 3B). Younger double mutant embryos were similar in size to
double heterozygous littermate controls and could only be distin-
guished (starting at E9.5) by their limb and inner ear agenesis.
Three-dimensional reconstructions of H&E-stained transverse
sections of E10.5 control and double mutant embryos (Figs. 3F–I)
revealed that some double mutants had a slightly shortened OFT
(Figs. 3F and G; white arrow). Double mutants also exhibited thin,
poorly trabeculated ventricles, dilated atria (Figs. 3H and I) and
unfused atrioventricular cushions (a/v; Figs. 3H–K); the latter may be
secondary to atrial dilation. Examination of the posterior pole of the
heart revealed a hypoplastic DMP in double mutants (dmp; Figs. 3L
and M). This structure arises from the posterior aspect of the SHF, and
contributes to the AV septal complex (Goddeeris et al., 2008;
Hoffmann et al., 2009; Snarr et al., 2007a, 2007b). More posterior
sections of the same pair of embryos showedmarked DMP hypoplasia
and failure of the DMP to fuse with the anterior IFT wall, with a
persistent connection of the pulmonary vein (PV) to both the left
atrium (LA) and sinus venosus (SV) in the double mutant (Figs. 3N
and O), analogous to IFT defects seen in amousemodel of human total
anomalous pulmonary venous return (TAPVR) (Bleyl et al., 2010).
To determine whether developmental heart defects could be
identiﬁed well before embryonic demise, control and double mutant
embryos harvested in the presence of verapamil to eliminate
contraction-state effects were compared at E9.5 (Figs. 3P–S).
Transverse sections were taken through the anterior (Figs. 3P and
Q) and middle (Figs. 3R and S) of the heart. In contrast to controls,
both double mutant embryos examined showed hypoplastic AV
cushions (Figs. 3Q and S, large red arrows), thin and poorly
trabeculated myocardium (Figs. 3Q and S red carets) and detached
endocardium that could be due to poor adhesion or excessive cardiac
jelly (Fig. 3Q, small arrow). Transverse sections taken through the OFT
of E11.0 embryos (shown in Figs. 3D and E) revealed a hypocellular
OFT in the double mutant (Fig. 3U, red arrow) relative to the control
littermate (Fig. 3T). Sections taken through the middle of the heart
Fig. 1. Embryos carrying both combinations of three Fgf3 and Fgf10 null alleles have abnormal OFT development. H&E-stained transverse sections taken through the anterior heart of
E11.5–E13.5 embryos. Genotypes are abbreviated to the left of each row (3, Fgf3; 10, Fgf10). Embryonic age is indicated at the top of each column. (A) E13.5 Fgf3−/+;Fgf10−/+
(control) embryo demonstrating normal outﬂow tract (OFT) directionality (white arrow) and septation of the aorta (ao) and pulmonary trunk (pt). Similarly staged Fgf3−/−
(B), Fgf10−/− (D), and Fgf3−/+;Fgf10−/− (E) embryos also showed normal OFT septation and patterning. (C) Fgf3−/−;Fgf10−/+ was the only genotype presenting at E13.5 with PTA
and a rightward-oriented OFT (red arrow). (F) E12.5 control embryo demonstrating normal communication of the aorta with the left ventricle (LV, black arrows). Aortic OFT
development was also normal in E12.5 Fgf3−/− (G), and Fgf10−/− (I) mutants. Both triple allelic mutants, Fgf3−/−;Fgf10−/+ (H) and Fgf3−/+;Fgf10−/− (J) showed a right-oriented
aortic outﬂowwith no apparent communication of the aorta with the LV. E11.5 control embryos (K), as well as Fgf3−/− (L), Fgf10−/− (N) and Fgf3−/+;Fgf10−/− (O) mutant exhibited
a patent OFT and normal myocardial wall thickness with robust trabeculation. (M) Fgf3−/−;Fgf10−/+was the only genotype presenting at E11.5 with OFT occlusion (red arrow) and
thin, poorly trabeculated ventricles. Scale bars in panels A, F and K apply to all panels in their respective columns. A=400 μm; F, K=200 μm.
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myocardium, and greatly reduced trabeculation in the double mutant
(Fig. 3W). Such defects suggest cardiac insufﬁciency as a primary
cause of double mutant lethality.
In addition to the defects found in the heart proper, the majority of
the E10.5 3D-reconstructed double mutants appeared to lack a patent
PAA4, suggesting a peripheral vascular defect. To evaluate the
peripheral vasculature directly, we injected ink into the common
ventricle at E10.5 and assessed its trajectory. Whereas PAA3, PAA4
and PAA6 were clearly patent in control embryos (Fig. 4A), PAA4 was
not apparent in three of four double mutants (Fig. 4B). Analysis ofhistologic sections conﬁrmed the absence, or lack of patency, of PAA4
in all three double mutants prepared at this stage, and this was
associated with apparent failure of segmentation of the 4th
pharyngeal arch (Figs. 4C and D). Thus, Fgf3 and Fgf10 are required
redundantly for normal formation of the 4th pharyngeal arch and
formation or stabilization of PAA4.
Taken together, the cardiovascular defects found in Fgf3/Fgf10
double mutants are more severe than those found in Fgfr2b mutants
(Marguerie et al., 2006), implicating additional FGF receptors in their
pathogenesis. Furthermore, the abnormalities are indicative of
perturbations in multiple cardiac progenitor cell populations.
Fig. 2. Defects in ventricular septum formation, myocardial expansion, epicardial cell attachment and pulmonary artery formation are observed in embryos carrying combinations of
three Fgf3 and Fgf10 null alleles. H&E-stained transverse sections of E12.5–E13.5 embryos. Genotypes are abbreviated to the left of each row as in Fig. 1. Embryonic age is indicated at
the top of each column. (A–E) Sections taken through the middle of E13.5 hearts. (A) Control embryo demonstrating a normal interventricular septum (ivs) between the right (rv)
and left (lv) ventricles. (B, C, E) Unfused ventricular septa (red arrows) were found in Fgf3−/−, Fgf3−/−;Fgf10−/+ and Fgf3−/+;Fgf10−/− embryos. The Fgf3−/−;Fgf10−/+ mutant
(C) also shows thin atrial and ventricular myocardial walls and poor trabeculation. (F–O) Sections taken through the middle of E12.5 hearts and photographed at low magniﬁcation
(F–J). Boxed region is enlarged in the adjacent panels (K–O). Control (F, K) and Fgf3−/− embryos (G, L) showed tight association of the epicardial layer with the underlying
myocardium (K, L black arrows). One of three Fgf10−/− embryos (I, N) showed some epicardial detachment (red arrow; in contrast to tightly associated regions, black arrow). In
contrast, in Fgf3−/+;Fgf10−/− mutants (J, O) and even more strikingly in Fgf3−/−;Fgf10−/+ mutants (H, M) epicardial layers were very loosely attached to the myocardium (red
arrows). Similarly, the endocardial layer in Fgf3−/−;Fgf10−/+mutants (M, red caret) also showed poor association with themyocardium compared to the other genotypes (e.g., black
caret in L). (P–T) Sections taken through the posterior pole of E13.5 hearts. Control (P) and Fgf3−/− (Q) embryos showed normal pulmonary artery development (two patent vessels
inside white circle). Fgf10−/− (S), Fgf3−/+;Fgf10−/− (T) and Fgf3−/−;Fgf10−/+ (R) mutants lacked pulmonary arteries (dotted red circle encloses expected location). Scale bars in
panels A, F, K and P apply to all panels in their respective columns. A=400 μm; F=200 μm; K=50 μm; P=200 μm.
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development
To correlate expression of Fgf3 and Fgf10with the tissues relevant to
normal cardiovasculardevelopment,we employedwholemountRNA in
situ hybridization of E8.0–E10.5 embryos. At E8.0, Fgf3 was detected in
hindbrain neural ectoderm (ne), the preotic and pharyngeal ectoderm(poe, phe) and in pharyngeal pouch endoderm (ppe, Figs. 5A and A1),
each of which is adjacent to the origin and/or migration path of neural
crest and second heart ﬁeld mesoderm. At the same stage, Fgf10 was
expressed in the SHF (shf, Figs. 5E and E1), which contributes primarily
to the OFT, right ventricle and IFT (Dyer and Kirby, 2009; Rochais et al.,
2009; Snarr et al., 2008). At E8.5, Fgf3 persisted in neural ectoderm of
rhombomeres 5 and 6, and in pharyngeal pouch endoderm (Figs. 5B and
Fig. 3. Fgf3/Fgf10doublenullmutantshavecardiovascular defects related to impaireddevelopmentof theheartﬁelds andneural crest. (A–C)FreshlydissectedE10.5 Fgf3−/+;Fgf10−/+ (control)
and Fgf3−/−;Fgf10−/− (double mutant) embryos. Relative to controls (A), most double mutant littermates (B) were smaller, often with small pericardial effusions (pe) not obvious in this
particular specimen. Other double mutant littermates showed striking cardiac malformations, such as a distended heart tube and large pe (C). (D–E) Freshly dissected E11.0–11.5 control
and double mutant littermates. Relative to the control (D), there was signiﬁcant blood pooling, a pericardial effusion, clearly thinned ventricles and poor to no heartbeat in the doublemutant
(E). (F–K) 3-D reconstructions of H&E-stained transverse sections of E10.5 control (F, H, J) and doublemutant embryos (G, I, K)with blood-ﬁlled internal space pseudo-colored in red. Double
mutant-speciﬁc defects included a shortenedOFT (G,white arrow), dilated atria (at) and thin ventricles (red arrow) (I), and reduced trabeculation (K, red arrow) and unfused atrioventricular
(a/v) cushions (I, K). (L–O)TransverseH&E-stained sections taken at two levels throughE10.5 inﬂow tracts. Relative to controls (L, N), the anterior extent of theDMPwashypoplastic in double
mutants (M).More posterior sections showed that doublemutants hadmarkedDMPhypoplasia (O; dmp cells lie between the lines) and that the DMP failed to fusewith the anterior IFTwall,
leaving a persistent connection of the pulmonary vein (pv) to both the left atrium (LA) and sinus venosus (SV). (P–S) H&E-stained transverse sections of control and double mutant hearts at
E9.5. Relative to anterior control sections (P, R), double mutants showed hypoplastic A/V cushions (Q, S red arrow) and thinned atrial and ventricular walls and poor trabeculation (Q, S red
caret), and detached endocardium (Q short red arrow). Sections taken through E11.0 control (T, V) and double mutant (U, W) hearts showed hypocellular OFT cushions in double mutants
(U, red arrow) and arrested, poorly developed myocardium with markedly reduced ventricular trabeculation (W). Panels L–U, scale bar=100 μm; panels V–W, scale bar=200 μm.
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Fig. 4. Fgf3/Fgf10 double null mutants fail to form a patent pharyngeal arch artery 4.
(A, B) India ink injection into the common ventricle of E10.5 control (A) and double
mutant (B) embryos showed that pharyngeal arch artery 4 was missing in double
mutants. (C, D) H&E-stained coronal sections of E10.5 control (C) and double mutant
(D) embryos revealed almost complete failure of 4th PA segmentation and severe 4th
PAA hypoplasia in double mutants.
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At this stage, Fgf10 expression initiated in the otic cup (adjacent to
migrating neural crest) and in the ﬁrst pharyngeal pouch endoderm,
and persisted in pharyngeal mesoderm (pm, Figs. 5F1 and F2). At E9.5,
Fgf3 persisted in the neural ectoderm and pharyngeal pouch endoderm
(Figs. 5C and C1), whereas Fgf10 persisted in the ﬁrst pharyngeal pouch
endoderm (1ppe) and pharyngealmesoderm (Figs. 5G and G1) andwas
initiated in the septum transversum and PEO (peo, Figs. 5G and G2),
which provides migratory progenitors for the epicardium and its
derivatives (Lie-Venema et al., 2007; Ratajska et al., 2008; Reese et al.,
2002). ByE10.0, neurectodermal Fgf3 expression ceased, but pharyngeal
endodermal expressionpersisted (Figs. 5D andD1) and Fgf10expression
persisted in the anterior pharyngeal endodermal and mesodermal
tissues (Figs. 5H and H1) and in the PEO (Figs. 5H and H2). Collectively,
these data show that Fgf3 and Fgf10 are expressed dynamically in or
immediately adjacent to tissues contributing to cardiovascular devel-
opment, including the neural crest, pharyngeal ectoderm and endo-
derm, FHF and SHF and the PEO, with overlapping expression detected
only in a small segment of the anterior pharyngeal endoderm.Fgf3 and Fgf10 are required redundantly for deployment of postotic
neural crest
Fgf3 is expressed in the hindbrain adjacent to the most anterior
region from which the postotic neural crest emerges, and in both the
pharyngeal endoderm and ectoderm adjacent to themigratory path of
these cells as they contribute to cranial ganglia, pharyngeal arch
arteries and the OFT septum. Fgf10 is expressed in mesenchyme
subjacent to the forming neural crest and in the pharyngeal
endoderm. To determine whether Fgf3 and Fgf10 play roles in neural
crest development, we stained E10.5 control and double null mutant
embryos with Tuj1 antibody, which marks differentiated neurons,
many of which are neural crest- or placode-derived at this stage
(Figs. 6A and B). As expected, the double mutants lacked the otic
placode-derived otic ganglion neurons (VIII; Figs. 6B and B1) (Alvarez
et al., 2003; Urness et al., 2010; Wright and Mansour, 2003). The
doublemutants also lacked the neural crest-derived glossopharyngealganglion neurons (proximal (p) IXth;), but retained the epibranchial
placode-derived petrosal ganglion neurons (distal (d) IXth; Figs. 6B
and B1). All of the other cranial ganglia (both neural crest- and
epibranchial placode-derived) and trunk ganglia appeared normal in
double mutants, and all cranial ganglia were normal in both Fgf3−/−
and Fgf10−/− embryos (data not shown), suggesting a speciﬁc defect
in postotic neural crest development in Fgf3/Fgf10 double null
mutants.
To determine whether the loss of glossopharyngeal ganglion
neurons in double mutants resulted from failure of neural crest
speciﬁcation, migration or differentiation, we investigated a number
of neural crest markers in control and double null mutant embryos
between E8.5 and E10.5 (Figs. 6C–N). Expression of Sox9 at E8.5 in
newly speciﬁed neural crest cells located at the border of the neural
and non-neural ectoderm, was not affected in double mutants
(Figs. 6C and D). Similarly, expression ofWnt1 at E9.0 in premigratory
neural crest located along the entire dorsal aspect of the anteropos-
terior axis, was not affected in double mutants (Figs. 6E and F). The
same was true at this stage for Cadh6 and Pax3 (data not shown).
These results show that Fgf3 and Fgf10 are not required for neural
crest speciﬁcation.
Sox10 labels migratory neural crest and was expressed relatively
normally at E9.0, when only preotic neural crest cells were migrating
ventrally from r2 and r4 (white arrows; Figs. 6G and H). In contrast,
relative to controls (Figs. 6I and K), E9.5–E10.5 Fgf3/Fgf10 double
mutants had much reduced Sox10-positive postotic neural crest (pnc)
streams migrating away from r6 to form the IX–XI ganglia, or
continuing to migrate through the pharyngeal arches and towards the
heart (Figs. 6J and L). Similar results were obtained with a Cadh6
probe (data not shown). In addition, the Sox10-expressing spur of
neural crest that normally migrates into the fourth arch was absent
(Figs. 6M and N), possibly reﬂecting the loss of the arch. Finally, since
loss of Fgf15 function leads to aberrant CNC behavior and consequent
OFT and alignment defects (Vincentz et al., 2005), we examined its
expression at E9.0 and E10.0, but observed no change in Fgf3/Fgf10
double mutants (data not shown).
Taken together, these data show that Fgf3 and Fgf10 are required
for normal migration and/or survival of a subset of neural crest,
including that which contributes neurons and glia to the proximal
ninth ganglia, participates in outﬂow tract septation and eventually
contributes smooth muscle to PAA4. Furthermore, Fgf3 and Fgf10
function independently of effects on Fgf15.
Expression of Tbx1 and Fgf8 is unaffected in Fgf3/Fgf10 double null
mutants
Anomalies of PAA4 and outﬂow tract development similar to those
seen in the Fgf3/Fgf10 double mutants occur commonly in humans
with DiGeorge and other 22q11 deletion syndromes and are
phenocopied in mice bearing mutations in Tbx1 or Fgf8 (Abu-Issa
et al., 2002; Frank et al., 2002; Lindsay et al., 2001). Indeed, Tbx1 and
Fgf8 genetically interact in the development of PAA4 (Aggarwal et al.,
2006; Vitelli et al., 2002). Therefore, to determine whether cardio-
vascular phenotypes of Fgf3/Fgf10 double mutants were related to
misregulation of Tbx1 and/or Fgf8, we examined their expression in
the pharyngeal region of control and double mutant embryos. Neither
gene was affected in double mutants from E8.5–10.5 (Figs. 7A–F and
data not shown), even when 4th pharyngeal arch hypoplasia was
obvious (Fig. 7F1).
Wnt11 is a target of Fgf8 (Park et al., 2006; Park et al., 2008) and a
marker of the OFT (Cai et al., 2003) that is required for OFT alignment
and septation (Zhou et al., 2007), however, neither Wnt11 nor Tdgf1
(Cripto), another OFT-expressed gene (Xu et al., 1999), was
misregulated in Fgf3/Fgf10 double mutants (Suppl. Fig. 2). These
data suggest that the requirement for Fgf3 and Fgf10 in cardiovascular
development is independent or downstream of Tbx1 and Fgf8.
Fig. 5. Fgf3 and Fgf10 are expressed in locations relevant to cardiovascular development. Whole-mount in situ hybridization of wild type embryos using Fgf3 (A–D) or Fgf10 (E–H)
probes at E8.0–E10.0. A line indicates the plane of cryosections shown below each whole mount. Fgf3 transcripts were found in pharyngeal pouch endoderm (ppe) from E8.0–E10.0
(A1, B1, C1, D1), in preotic ectoderm (poe) at E8.0 (A1), and hindbrain rhombomeres 5 and 6 neural ectoderm (ne) from E8.0–E9.5 (A1, B1, C1), but not in more posterior ne (B2). Fgf10
was found in the second heart ﬁeld (shf) at E8.0 (E1), initiated in the ppe at E8.5 (F1), and persisted in the pharyngeal mesoderm (pm) and endoderm at E8.5–E10.0 (F1, F2, G1, H1).
Otic cup (oc) expression of Fgf10 was apparent at E8.5 (F1) and ppe expression was weak at E9.5–E10.0 (G1, H1). Fgf10 expression in the proepicardial organ (peo) was observed at
E9.5–E10.0 (G2, H2).
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perturbed in Fgf3/Fgf10 double mutants
Fgf3 and Fgf10 are required for and are expressed in or near the
developing FHF and SHF, so we examined molecular markers of these
progenitor populations and their descendants in control and double
mutant embryos (Fig. 8). Nkx2-5 encodes a critical transcriptional
regulator of the cardiac myogenic program (Ponticos, 2010). Its
expression was dramatically reduced in both atrial and ventricular
cardiomyocytes in two of three E10.5 double mutants (Figs. 8A, A1, B,
B1). Surprisingly, Nkx2-5 expression appeared normal at E9.5 (Figs. 8C
and D) and at E8.5 (data not shown). Expression of other
cardiomyocyte developmental markers, including Myl7 (Mlc2a),
Mef2c, Hand2 (dHand) and Nappa (Anf), was not altered in doublemutants (Suppl. Fig. 3), suggesting that the effect on Nkx2-5 may be
on the number of transcripts per cell, rather than a consequence of
reduced numbers of cardiomyocytes or global decline in transcription.
Isl1 is expressed in and required for development of the SHF (Cai
et al., 2003). Isl1 SHF expression in doublemutants was normal at E10.5
(data not shown) and at 19–20 somites (Figs. 8E and F), a half-day prior
to the ﬁrst morphologic manifestations of Fgf3/Fgf10 deﬁciency. In
contrast, Isl1 expressionwas absent from the second heart ﬁeld in three
of three E8.0 doublemutant embryos (7–8 somites, Figs. 8G andH and 4
somites Figs. 8I and J). However, Isl1 expressionwas robust in thedouble
mutant cardiac crescent at the 2–3-somite stage (Figs. 8K and L). Thus,
Isl1 expression appears to be transiently dependent upon Fgf3 and Fgf10
between the 4- and 20-somite stages, but may be regulated by other
factors prior and subsequent to this developmental window.
Fig. 6. Fgf3 and Fgf10 are required redundantly for deployment of post-otic neural crest. Whole mount immunohistochemistry with Tuj1 antibody labeled differentiated neurons in
E10.5 control (A) and double mutant (B) embryos. Dotted lines indicate the plane of cryosections shown below each embryo (A1, B1). Relative to controls (A, A1), double mutants
lacked the otic ganglion (VIII) and the neural crest-derived proximal glossopharyngeal ganglion (pIX), but retained the epibranchial placode-derived petrosal ganglion (dIX) (B, B1).
Whole mount in situ hybridization of control and double mutant embryos with Sox9 at E8.5 (C, D),Wnt1 at E9.0 (E, F) and Sox10 at E9.0 (G, H) showed that neural crest speciﬁcation
and early migration occurred normally in double mutants. In contrast, expression of Sox10 at E9.5–E10.5 (I–N) revealed that postotic neural crest migrating distally from the neural
tube and through the pharyngeal arches towards the heart was reduced in double mutants (J, L, red arrow). Sox10-positive cells weremarkedly reduced in the IXth ganglion as well as
in the Xth and XIth ganglia (red labels in L). A higher magniﬁcation view of the E10.5 pharyngeal region showed that Sox10marks a spur of neural crest transiting the 4th arch in the
control embryo (M, black arrow) that was absent from the double mutant (N, red arrow). Abbreviations: mv, micro-otic vesicle; ov, otic vesicle; pnc, post-otic neural crest; r2, r4,
rhombomeres 2, 4; V–XI refer to forming ganglia.
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expression (Cai et al., 2003), and transcripts from the Fgf10Δ2 (exon 2
deletion) allele we used are stable (RT-PCR data not shown), we were
able to test their expression as well. Like Isl1, Fgf10Δ2 transcripts were
unaffected in E9.5 double mutants (Figs. 8M and N), but were absent
or somewhat reduced in two of three 5–7-somite (E8.0) double
mutants (Figs. 8O and P). Similar to Isl1, Fgf10Δ2 transcripts were
strongly expressed in the cardiac crescent in 2–3-somite double
mutant embryos (Figs. 8Q and R).
Fgf8 is also required for SHF development and is needed prior to
E8.5 for normal levels of Isl1 expression (Park et al., 2006). Therefore,
we examined Fgf8 expression at several additional stages, prior to the
decrease in Isl1 expression, but no differences between control and
double mutant embryos were apparent, even in 1-somite embryos
(Figs. 8S and T), when the SHF is forming. Expression of Bmp4, a
prominent mediator of Fgf8 signaling in the OFT myocardium, wasalso unaffected in the OFT or chamber myocardium of Fgf3/Fgf10
double mutants in E9.5–10.5 embryos (data not shown).
Taken together, morphologic and marker analyses suggest that
Fgf3 and Fgf10 are not required to specify cardiac progenitors, but are
coordinately required to effect normal cellular contributions to the
developing heart from both the SHF and postotic neural crest and that
this requirement is independent of Fgf8.
Proepicardial cell deployment is reduced or delayed in Fgf3/Fgf10 double
mutants
The epicardium surrounding the heart is comprised of a thin layer
of cells mainly derived from the PEO, which develops at the base of the
heart on the anterior surface of the septum transversum. These cells
migrate anteriorly to ensheathe most of the developing myocardium
by E11.0. There is also a small population of epithelial cells in the
Fig. 7. Expression of Tbx1 and Fgf8 is unaffected in Fgf3/Fgf10 double null mutants. In
situ hybridization of control and double mutant embryos with Tbx1 and Fgf8. Relative to
controls (A, C, E, E1), there was no difference in double mutant embryos with respect to
expression of Tbx1 at E9.5 (B) or Fgf8 at E9.5 (D) and E10.5 (F, F1), evenwhen the double
mutant 4th PA was clearly hypoplastic (F1). In E, F dorsal is up, anterior to the right, and
dotted lines indicate the plane of coronal sections shown in E1, F1.
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distal OFT (Pérez-Pomares et al., 2003). The epicardium plays a vital
role in stimulating the proliferation of cardiomyocytes, and contrib-
uting to the coronary vessels and ﬁbrous interstitium of the maturing
heart (Männer et al., 2001; Ratajska et al., 2008; Virágh and Challice,
1981). Since triple-allelic mutants showed epicardial detachment, and
Fgf10 is expressed in the PEO at E9.5 (Figs. 5G–H2), we assessed the
development of this unique cell population in double mutants.
Examination of epicardial cell markers, Tcf21 (Figs. 9A–B2) and Tbx18
(data not shown) in E10.5 embryos, showed that, relative to control
embryos (Figs. 9A1 and A2), double mutants had fewer epicardial cells
encasing the developing OFT (Fig. 9B1) and ventricles (Fig. 9B2).
However, at E9.5, expression of PEO markers Gata4 (Figs. 9C–D1) and
Wnt2a (data not shown) was normal in double mutants, as was PEO
grossmorphology (data not shown). Thus, Fgf3 and Fgf10 are necessary
for epicardial cell development after the PEO is speciﬁed.
Discussion
Previous morphologic and molecular marker analyses of mouse
embryos lacking expression of three or all four alleles of Fgf3 and Fgf10
revealed critical redundant and dosage sensitive roles for these genes
in initiating inner ear development (Alvarez et al., 2003; Ladher et al.,
2005; Wright and Mansour, 2003). The present analyses of such
embryos show that Fgf3 and Fgf10 also play redundant and dosage
sensitive roles in cardiovascular development. We found that
removing one copy of Fgf3 from the Fgf10 null background causes
OFT alignment and rotation defects, VSD and moderate epicardial
detachment. Removing one copy of Fgf10 from the Fgf3 null
background causes OFT and rotation defects and, in one case, PTA.These embryos also displayed VSD, thin and poorly trabeculated
ventricular myocardium, severe epicardial detachment, pulmonary
artery aplasia and lung hypoplasia. These phenotypes have variable
penetrance and expressivity, with the Fgf3−/−;Fgf10−/+ genotype
causing earlier lethality and more severe and penetrant cardiovascu-
lar phenotypes than does the Fgf3−/+;Fgf10−/− genotype. Indeed, the
Fgf3−/−;Fgf10−/+ phenotypes are almost as severe as those of the
double mutants, which strikingly, all die at E11.5, exhibiting thin and
poorly trabeculated ventricular and atrial myocardium. This presum-
ably renders the heart unable to pump adequately and is the most
likely cause of embryonic demise. Other variably penetrant defects in
double mutants include absence of PAA4 and sometimes the entire
fourth pharyngeal arch, slightly shortened OFT, and a hypoplastic
DMP and OFT cushions. While serious, these defects are generally
compatible with survival to birth.
How do the Fgf3/Fgf10 double mutant cardiovascular phenotypes
arise? A model summarizing the expression patterns of Fgf3 and Fgf10
at two stages, and how they might signal to cardiovascular pro-
genitors is shown in Fig. 10. We propose that redundancy between
Fgf3 expressed from the hindbrain and Fgf10 expressed from the SHF
is required for normal deployment of postotic neural crest, leading to
loss of the proximal, neural crest-derived component of the
glossopharyngeal ganglion and failure of PAA4 to persist in double
null mutants, but not in Fgf3 or Fgf10 single null mutants. The PAA4
phenotype is similar to that observed following cardiac neural crest
ablation in chick embryos (Waldo et al., 1996) or loss of Fgf8 from
mouse embryos (Abu-Issa et al., 2002; Frank et al., 2002; Macatee
et al., 2003). When either an Fgf3 or Fgf10wild type allele remains (i.e.
in Fgf3−/+;Fgf10−/− or Fgf3−/−;Fgf10−/+ embryos), there is sufﬁcient
signal for proximal glossopharyngeal ganglion and PAA4 develop-
ment, but the CNC must still be somewhat impaired, leading to PTA
and/or VSD, evident at stages after double mutants die. Since neural
crest-restricted ablation of Fgfr1 and Fgfr2 (Park et al., 2008), encoding
the major receptors for FGF3 and FGF10, or of Frs2α (Zhang et al.,
2008), encoding an adaptor protein linking FGF receptors to theMAPK
and PI3 kinase pathways, does not disrupt CNC contribution to the
growing OFT, it is likely that FGF3 and FGF10 act indirectly on neural
crest. They could, for example, regulate SHF-expressed Bmp genes,
which are required to activate signaling through BMP receptors and
SMAD4 for normal development of neural crest as well as the SHF
(Azhar et al., 2010; McCulley et al., 2008; Qi et al., 2007; Song et al.,
2007; Yang et al., 2006). Indeed, some of the gross phenotypes seen in
Fgf3/Fgf10 double mutants are similar to those of neural crest-speciﬁc
ablation of Bmpr1a (Nomura-Kitabayashi et al., 2009; Stottmann et al.,
2004) or Smad4 (Jia et al., 2007; Ko et al., 2007; Nie et al., 2008).
Although we did not ﬁnd any change in myocardial Bmp4 expression
in the double mutants, there are several other candidates, including
Bmps 2, 6, 7 and 10 that could be affected. However, if FGF signaling
affects expression of multiple Bmps, each to only a small extent, such
differences would be difﬁcult to detect.
Although the effects of Fgf3/Fgf10 abrogation on postotic neural
crest are likely to be indirect, we have evidence for direct effects of
these signals on the SHF. Isl1, a key regulator of SHF development, was
transiently down-regulated at E8.5, and Nkx2-5 expression was
reduced only at E10.5, when other cardiomyocyte markers were
normally expressed. These results suggest that FGF3/FGF10 signals are
probably not required to initiate expression of these genes, but may
play important stage-speciﬁc roles in their subsequent regulation. The
consequences of a transient disruption of Isl1 expression have not
been reported previously, but this gene regulates many SHF genes,
including Fgf10 (Cai et al., 2003). Indeed, we found that the Fgf10Δ2
mutant transcript was absent or reduced in double mutants at E8.5,
but not at later stages. The interruption of Isl1 expression could lead to
transient alterations in additional target genes sufﬁcient to delay or
discoordinate second heart ﬁeld development relative to the neural
crest. The shortened OFT and hypoplastic DMP in Fgf3/Fgf10 double
Fig. 8. Markers of cardiac mesoderm development are transiently perturbed in Fgf3/Fgf10 double null mutants. In situ hybridization of control and double mutant embryos with
Nkx2-5, Isl1, Fgf10 and Fgf8. Relative to control embryos (A) Nkx2-5 expression was strongly reduced in double mutant hearts (B). Black lines indicate the plane of sections shown in
A1, B1. Expression of Nkx2-5 was comparable in E9.5 control and double mutant hearts (C, D; black arrows). Pharyngeal region Isl1 expression (bracketed) was similar in 19–20-
somite control (E) and double mutant embryos (F). In contrast, although Isl1 expression in the SHF of 7–8-somite controls was robust (G; black arrow), it was absent from the double
mutant SHF (H; red arrow). Similarly, SHF Isl1 expression was robust in 4–5-somite controls (I; black bracket), but absent from double mutants (J; red bracket). Isl1 was expressed
normally in the cardiac crescent of both 2–3-somite controls (K) and double mutants (L). Expression of the Fgf10Δ2 transcript in the pharyngeal region and right ventricle of E9.5
control and double mutants was similar (M, N; brackets). In contrast, while control 7-somite embryos showed stable Fgf10Δ2 transcripts in pharyngeal mesoderm (O; black bracket,),
they were less abundant in double mutant embryos (P; red bracket). Fgf10Δ2 transcripts were expressed similarly in the cardiac crescent of both 3–4-somite control and double
mutant embryos (Q, R). Fgf8 expression in the cardiac crescent was comparable in 1-somite control (wild type) (S) and double mutant embryos (T).
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expression at E10.5 of Nkx2-5, a key regulator of the cardiomyogenic
program in both FHF and SHF derivatives, could contribute to the thin
and poorly trabeculated walls of the Fgf3/Fgf10 double mutant
ventricular myocardium. However, the late timing of the Nkx2-5
loss suggests that it is not likely to be the primary cause of the
myocardial phenotype.
The morphologic and molecular defects found in Fgf3/Fgf10 double
mutant cardiac development do not occur in Fgf10 null mutants
(Marguerie et al., 2006), pointing to a key role for Fgf3 in their
pathogenesis. Since Fgf3 is expressed at early stages in the hindbrain
and endoderm located in close proximity to the SHF, the FGF3 signal
functioning redundantly with FGF10 to control SHF development
could arise from either or both locations. It is tempting to ascribe all of
the double mutant phenotypes to loss of Fgf3 from the hindbrain and
Fgf10 from the SHF, leading to postotic neural crest deﬁcits and
consequent discoordination of CNC and SHF development. However,
given the important roles already described for FGF signaling from the
endoderm to the SHF (Park et al., 2008; Zhang et al., 2008), potential
roles for endodermal Fgf3 should not be discounted, and can be tested
using conditional gene ablation approaches.SHF-expressed FGF8 is a key autocrine regulator of OFTdevelopment
(Ilaganet al., 2006; Park et al., 2006) and Fgf10 transcripts are reduced in
the SHF of Fgf8hypomorphic embryos (Abu-Issa et al., 2002; Frank et al.,
2002). Recent data show that the penetrance of PAA4 as well as OFT
defects in SHF conditional Fgf8mutants is increased by removal of Fgf10
alleles (Watanabe et al., 2010). Combinedwithourpreviously published
data showing that splanchnic mesodermal expression of Fgf10 is
reduced or absent in E8.0 Fgf3 null/Fgf8 hypomorphic embryos (Ladher
et al., 2005) and that Fgf8 expression is unaffected in similarly staged
Fgf3/Fgf10 double null mutants (this paper), we suggest that, as in otic
placode induction, Fgf8 functions upstream of Fgf10 during sequential
phases of FGF signaling in cardiovascular development, and that Fgf3
functions redundantly with each of these Fgfs.
In addition to effects on the neural crest and myocardium, we
found that Fgf3/Fgf10 double mutant hearts have reduced epicardial
cell ensheathment and the triple-allelic mutants, particularly Fgf3−/−;
Fgf10−/+, showed detachment of epicardial cells from the myocardi-
um. Epicardial cells are proposed to play important roles in at least
stimulating myocardial growth and possibly in providing additional
cells to the myocardium, in addition to their ultimate fate as
progenitors of coronary vessels and interstitium (Carmona et al.,
Fig. 9. Fgf3 and Fgf10 are required redundantly for normal epicardial cell deployment over the heart, but not for initial speciﬁcation of the proepicardial organ. (A–D)Wholemount in
situ hybridization of control and double mutant embryos with epicardial markers Tcf21 (Epicardin) and Gata4. Lines through each embryo indicate the planes of sections shown
below each embryo. Relative to control embryos, which showed robust ensheathment of the OFT and ventricles with Tcf21-positive epicardial cells (A1, A2 black arrows), the double
mutant OFT (B1, red arrow) and ventricle (B2, red arrow) were deﬁcient in such cells. No differences with respect to Gata4 expression (black arrows) were apparent between control
(C, C1) and double mutant (D, D1) embryos.
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Indeed, ablation of the chick PEO, the major source of epicardial cells,
leads to thin myocardium in addition to loss of the coronary
vasculature (Männer et al., 2005; Pérez-Pomares et al., 2002).
However, impairment of epicardial cell function seems unlikely to
be the sole cause of the myocardial phenotype and early demise of
Fgf3/Fgf10 double mutant embryos, which occurs prior to establishedFig. 10. Model for Fgf3 and Fgf10 expression and function during cardiovascular developm
views, respectively) are shown at E8.0 and E9.5–10.0. At early stages, Fgf10 expression in the
Fgf3 expressed from the hindbrain (purple) and/or endoderm, which also expresses Fgf10 (g
of signals required for subsequent neural crest (NC) development. Both Fgf3 and Fgf10 are als
Fgf3 and Fgf10 expressed in the pharyngeal endoderm (green), and with or without Fgf10 ex
NC (arrow c) and/or the cardiogenic mesoderm (CM, arrows d, e). Although there is no sourc
signals to the SHF could be required with PEO-expressed Fgf10 (arrow f) to regulate ensheath
signals from the PEO could inﬂuence the CM. Abbreviations: Ecto, ectoderm (blue); Endo, e
PEO, proepicardial organ; SHF, second heart ﬁeld.critical roles for the epicardium. However, such an early functional
role for the mouse epicardium cannot be discounted and could be
addressed directly by genetic ablation of the PEO lineage.
Another question concerning the epicardial phenotype described
here is whether it is a direct or indirect consequence of loss of Fgf3 and
Fgf10. Fgf10 is certainly expressed in the PEO and could stimulate its
proliferation, as proposed in chick (Torlopp et al., 2010), or itsent. Embryonic structures and expression of Fgf3 and Fgf10 (left and right of sectional
SHF (red) could be directly required for SHF development (arrow a) in conjunction with
reen) (arrow b). An indirect effect of FGF3/FGF10 signaling to SHF could be perturbation
o expressed at later stages, and could continue to inﬂuence cardiovascular development.
pression from the pharyngeal mesoderm (orange), could indirectly affect the migratory
e of Fgf3 in the vicinity of the proepicardial organ (PEO), earlier redundant FGF3/FGF10
ment of the heart by migrating proepicardial cells. Alternatively, contributions of FGF10
ndoderm (yellow); CM, cardiogenic mesoderm; FHF, ﬁrst heart ﬁeld; NC, neural crest;
396 L.D. Urness et al. / Developmental Biology 356 (2011) 383–397migratory behavior, or even its ability to adhere to the myocardium,
but it must do so in conjunctionwith Fgf3, which is not expressed near
the PEO at times when the phenotype is observed. Another possibility
is that the failure of myocardial ensheathment by proepicardial cells is
an indirect consequence of a “sick”myocardium caused more directly
by loss of FGF3/FGF10 signaling to the early progenitors of the
myocardium (i.e. in the FHF and SHF). Resolving this issue will require
conditional analyses.
What is the relevance of our ﬁndings to the etiology of congenital
heart defects in humans? Mutations in FGF3 and FGF10 are each
associated with multiple malformation syndromes. Homozygosity for
recessive loss-of-function mutations in FGF3 causes LAMM (labyrin-
thine aplasia–microdontia–microtia) syndrome (Tekin et al., 2008)
and those in FGF10 cause LADD (lacrimo-auriculo-dento-digital)
syndrome (Rohmann et al., 2006). Neither of these very rare
syndromes has been associated with heart defects; however, neither
gene has been examined in large groups of patients with isolated
heart defects. Furthermore, the convergence of inner ear and
cardiovascular developmental defects in double mutant mouse
embryos has parallels with human syndromes such as DiGeorge and
CHARGE, which are caused, in part, by mutations in TBX1 and CHD7,
respectively, and are modeled in Tbx1, Fgf8 and Chd7mutant mice.We
suggest that FGF3 and FGF10 should now be considered candidates for
genes that whenmutated or misregulated contribute to isolated heart
defects, and particularly to congenital syndromes presenting with
cardiovascular defects and hearing loss.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.05.671.Acknowledgments
We thank Albert Noyes for superb technical support, and
particularly for the Fgf8 ISH on 1-somite embryos, and Katie Barrows,
Sam Gliford and Jennifer Hunter for help with histology and heart
reconstructions. We thank Yukio Saijoh for helpful comments on the
manuscript. In addition, we are grateful to the numerous colleagues
who supplied probes for ISH. This work was supported by grants from
the American Heart Association (0755150Y, S.L.M.) and the NIH
(DC004185, S.L.M.; HL084559, S.B.B; HD044157, A.M.M).References
Abu-Issa, R., Kirby, M.L., 2007. Heart ﬁeld: frommesoderm to heart tube. Annu. Rev. Cell
Dev. Biol. 23, 45–68.
Abu-Issa, R., Smyth, G., Smoak, I., Yamamura, K., Meyers, E.N., 2002. Fgf8 is required for
pharyngeal arch and cardiovascular development in the mouse. Development 129,
4613–4625.
Aggarwal, V.S., Liao, J., Bondarev, A., Schimmang, T., Lewandoski, M., Locker, J., Shanske,
A., Campione, M., Morrow, B.E., 2006. Dissection of Tbx1 and Fgf interactions in
mouse models of 22q11DS suggests functional redundancy. Hum. Mol. Genet. 15,
3219–3228.
Alvarez, Y., Alonso, M.T., Vendrell, V., Zelarayan, L.C., Chamero, P., Theil, T., Bösl, M.R.,
Kato, S., Maconochie, M., Riethmacher, D., Schimmang, T., 2003. Requirements for
FGF3 and FGF10 during inner ear formation. Development 130, 6329–6338.
Azhar, M., Wang, P.Y., Frugier, T., Koishi, K., Deng, C., Noakes, P.G., McLennan, I.S., 2010.
Myocardial deletion of Smad4 using a novel alpha skeletal muscle actin Cre
recombinase transgenic mouse causes misalignment of the cardiac outﬂow tract.
Int. J. Biol. Sci. 6, 546–555.
Bleyl, S.B., Saijoh, Y., Bax, N.A., Gittenberger-de Groot, A.C., Wisse, L.J., Chapman, S.C.,
Hunter, J., Shiratori, H., Hamada, H., Yamada, S., Shiota, K., Klewer, S.E., Leppert, M.F.,
Schoenwolf, G.C., 2010. Dysregulation of the PDGFRA gene causes inﬂow tract
anomalies including TAPVR: integrating evidence from human genetics and model
organisms. Hum. Mol. Genet. 19, 1286–1301.
Brown, C.B., Wenning, J.M., Lu, M.M., Epstein, D.J., Meyers, E.N., Epstein, J.A., 2004. Cre-
mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for
Fgf8 in cardiovascular development in the mouse. Dev. Biol. 267, 190–202.
Bruneau, B.G., 2008. The developmental genetics of congenital heart disease. Nature
451, 943–948.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., Evans, S., 2003. Isl1 identiﬁes a
cardiac progenitor population that proliferates prior to differentiation and
contributes a majority of cells to the heart. Dev. Cell 5, 877–889.Carmona, R., Guadix, J.A., Cano, E., Ruiz-Villalba, A., Portillo-Sánchez, V., Pérez-Pomares,
J.M., Munoz-Chápuli, R., 2010. The embryonic epicardium: an essential element of
cardiac development. J. Cell. Mol. Med. 14, 2066–2072.
Chien, K.R., Domian, I.J., Parker, K.K., 2008. Cardiogenesis and the complex biology of
regenerative cardiovascular medicine. Science 322, 1494–1497.
Chisaka, O., Musci, T.S., Capecchi, M.R., 1992. Developmental defects of the ear, cranial
nerves and hindbrain resulting from targeted disruption of the mouse homeobox
gene Hox-1.6. Nature 355, 516–520.
Conway, S.J., Kruzynska-Frejtag, A., Kneer, P.L., Machnicki, M., Koushik, S.V., 2003. What
cardiovascular defect doesmyprenatalmousemutant have, andwhy?Genesis 35, 1–21.
Dyer, L.A., Kirby, M.L., 2009. The role of secondary heart ﬁeld in cardiac development.
Dev. Biol. 336, 137–144.
Frank, D.U., Fotheringham, L.K., Brewer, J.A., Muglia, L.J., Tristani-Firouzi, M., Capecchi,
M.R., Moon, A.M., 2002. An Fgf8mouse mutant phenocopies human 22q11 deletion
syndrome. Development 129, 4591–4603.
Gittenberger-de Groot, A.C., Winter, E.M., Poelmann, R.E., 2010. Epicardium-derived
cells (EPDCs) in development, cardiac disease and repair of ischemia. J. Cell. Mol.
Med. 14, 1056–1060.
Goddeeris, M.M., Rho, S., Petiet, A., Davenport, C.L., Johnson, G.A., Meyers, E.N.,
Klingensmith, J., 2008. Intracardiac septation requires hedgehog-dependent
cellular contributions from outside the heart. Development 135, 1887–1895.
Hatch, E.P., Noyes, C.A., Wang, X., Wright, T.J., Mansour, S.L., 2007. Fgf3 is required for
dorsal patterning and morphogenesis of the inner ear epithelium. Development
134, 3615–3625.
Hoffmann, A.D., Peterson, M.A., Friedland-Little, J.M., Anderson, S.A., Moskowitz, I.P.,
2009. Sonic hedgehog is required in pulmonary endoderm for atrial septation.
Development 136, 1761–1770.
Ilagan, R., Abu-Issa, R., Brown, D., Yang, Y.P., Jiao, K., Schwartz, R.J., Klingensmith, J.,
Meyers, E.N., 2006. Fgf8 is required for anterior heart ﬁeld development.
Development 133, 2435–2445.
Itoh, N., Ornitz, D.M., 2008. Functional evolutionary history of the mouse Fgf gene
family. Dev. Dyn. 237, 18–27.
Jia, Q., McDill, B.W., Li, S.Z., Deng, C., Chang, C.P., Chen, F., 2007. Smad signaling in the
neural crest regulates cardiac outﬂow tract remodeling through cell autonomous
and non-cell autonomous effects. Dev. Biol. 311, 172–184.
Kelly, R.G., Brown, N.A., Buckingham, M.E., 2001. The arterial pole of the mouse heart
forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 1, 435–440.
Kirby, M.L., Hutson, M.R., 2010. Factors controlling cardiac neural crest cell migration.
Cell Adh. Migr. 4 Epub ahead of print.
Kirby, M.L., Turnage III, K.L., Hays, B.M., 1985. Characterization of conotruncal
malformations following ablation of “cardiac” neural crest. Anat. Rec. 213, 87–93.
Ko, S.O., Chung, I.H., Xu, X., Oka, S., Zhao, H., Cho, E.S., Deng, C., Chai, Y., 2007. Smad4 is
required to regulate the fate of cranial neural crest cells. Dev. Biol. 312, 435–447.
Ladher, R.K., Wright, T.J., Moon, A.M., Mansour, S.L., Schoenwolf, G.C., 2005. FGF8
initiates inner ear induction in chick and mouse. Genes Dev. 19, 603–613.
Lie-Venema, H., van den Akker, N.M., Bax, N.A., Winter, E.M., Maas, S., Kekarainen, T.,
Hoeben, R.C., deRuiter, M.C., Poelmann, R.E., Gittenberger-de Groot, A.C., 2007.
Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and
abnormal cardiac development. ScientiﬁcWorldJournal 7, 1777–1798.
Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V.,
Ogunrinu, G., Sutherland, H.F., Scambler, P.J., Bradley, A., Baldini, A., 2001. Tbx1
haploinsufﬁciency in the DiGeorge syndrome region causes aortic arch defects in
mice. Nature 410, 97–101.
Macatee, T.L., Hammond, B.P., Arenkiel, B.R., Francis, L., Frank, D.U., Moon, A.M., 2003.
Ablation of speciﬁc expression domains reveals discrete functions of ectoderm- and
endoderm-derived FGF8 during cardiovascular and pharyngeal development.
Development 130, 6361–6374.
Männer, J., Pérez-Pomares, J.M., Macías, D., Muñoz-Chápuli, R., 2001. The origin,
formation and developmental signiﬁcance of the epicardium: a review. Cells
Tissues Organs 169, 89–103.
Männer, J., Schlueter, J., Brand, T., 2005. Experimental analyses of the function of the
proepicardium using a new microsurgical procedure to induce loss-of-proepicardial-
function in chick embryos. Dev. Dyn. 233, 1454–1463.
Mansour, S.L., Goddard, J.M., Capecchi, M.R., 1993. Mice homozygous for a targeted
disruption of the proto-oncogene int-2 have developmental defects in the tail and
inner ear. Development 117, 13–28.
Marguerie, A., Bajolle, F., Zaffran, S., Brown, N.A., Dickson, C., Buckingham, M.E., Kelly, R.G.,
2006. Congenital heart defects inFgfr2-IIIband Fgf10mutantmice.Cardiovasc. Res. 71,
50–60.
McCulley, D.J., Kang, J.O., Martin, J.F., Black, B.L., 2008. BMP4 is required in the anterior
heart ﬁeld and its derivatives for endocardial cushion remodeling, outﬂow tract
septation, and semilunar valve development. Dev. Dyn. 237, 3200–3209.
Meyers, E.N., Martin, G.R., 1999. Differences in left–right axis pathways in mouse and
chick: functions of FGF8 and SHH. Science 285, 403–406.
Min, H., Danilenko, D.M., Scully, S.A., Bolon, B., Ring, B.D., Tarpley, J.E., DeRose,M., Simonet,
W.S., 1998. Fgf-10 is required for both limband lungdevelopment andexhibits striking
functional similarity to Drosophila branchless. Genes Dev. 12, 3156–3161.
Mommersteeg, M.T., Dominguez, J.N., Wiese, C., Norden, J., de Gier-de Vries, C., Burch, J.B.,
Kispert, A., Brown, N.A., Moorman, A.F., Christoffels, V.M., 2010. The sinus venosus
progenitors separate and diversify from the ﬁrst and second heart ﬁelds early in
development. Cardiovasc. Res. 87, 92–101.
Moon, A., 2008. Mouse models of congenital cardiovascular disease. Curr. Top. Dev. Biol.
84, 171–248.
Nie, X., Deng, C.X., Wang, Q., Jiao, K., 2008. Disruption of Smad4 in neural crest cells
leads to mid-gestation death with pharyngeal arch, craniofacial and cardiac defects.
Dev. Biol. 316, 417–430.
397L.D. Urness et al. / Developmental Biology 356 (2011) 383–397Nomura-Kitabayashi, A., Phoon, C.K., Kishigami, S., Rosenthal, J., Yamauchi, Y., Abe, K.,
Yamamura, K., Samtani, R., Lo, C.W., Mishina, Y., 2009. Outﬂow tract cushions
perform a critical valve-like function in the early embryonic heart requiring
BMPRIA-mediated signaling in cardiac neural crest. Am. J. Physiol. Heart Circ.
Physiol. 297, H1617–H1628.
Park, E.J., Ogden, L.A., Talbot, A., Evans, S., Cai, C.L., Black, B.L., Frank, D.U., Moon, A.M.,
2006. Required, tissue-speciﬁc roles for Fgf8 in outﬂow tract formation and
remodeling. Development 133, 2419–2433.
Park, E.J., Watanabe, Y., Smyth, G., Miyagawa-Tomita, S., Meyers, E., Klingensmith, J.,
Camenisch, T., Buckingham, M., Moon, A.M., 2008. An FGF autocrine loop initiated
in second heart ﬁeld mesoderm regulates morphogenesis at the arterial pole of the
heart. Development 135, 3599–3610.
Pérez-Pomares, J.M., Phelps, A., Sedmerova, M., Carmona, R., González-Iriarte, M.,
Muñoz-Chápuli, R., Wessels, A., 2002. Experimental studies on the spatiotemporal
expression of WT1 and RALDH2 in the embryonic avian heart: a model for the
regulation of myocardial and valvuloseptal development by epicardially derived
cells (EPDCs). Dev. Biol. 247, 307–326.
Pérez-Pomares, J.M., Phelps, A., Sedmerova, M., Wessels, A., 2003. Epicardial-like cells
on the distal arterial end of the cardiac outﬂow tract do not derive from the
proepicardium but are derivatives of the cephalic pericardium. Dev. Dyn. 227,
56–68.
Ponticos, M., 2010. The role of the homeodomain transcription factor Nkx2-5 in the
cardiovascular system. In: Abraham, D., et al. (Ed.), Advances in Vascular Medicine.
Springer, London, pp. 113–130.
Qi, X., Yang, G., Yang, L., Lan, Y., Weng, T., Wang, J., Wu, Z., Xu, J., Gao, X., Yang, X., 2007.
Essential role of Smad4 in maintaining cardiomyocyte proliferation during murine
embryonic heart development. Dev. Biol. 311, 136–146.
Ratajska, A., Czarnowska, E., Ciszek, B., 2008. Embryonic development of the
proepicardium and coronary vessels. Int. J. Dev. Biol. 52, 229–236.
Reese, D.E., Mikawa, T., Bader, D.M., 2002. Development of the coronary vessel system.
Circ. Res. 91, 761–768.
Rochais, F., Mesbah, K., Kelly, R.G., 2009. Signaling pathways controlling second heart
ﬁeld development. Circ. Res. 104, 933–942.
Rohmann, E., Brunner, H.G., Kayserili, H., Uyguner, O., Nürnberg, G., Lew, E.D., Dobbie,
A., Eswarakumar, V.P., Uzumcu, A., Ulubil-Emeroglu, M., Leroy, J.G., Li, Y., Becker, C.,
Lehnerdt, K., Cremers, C.W., Yüksel-Apak, M., Nürnberg, P., Kubisch, C., Schles-
singer, J., van Bokhoven, H., Wollnik, B., 2006. Mutations in different components of
FGF signaling in LADD syndrome. Nat. Genet. 38, 414–417.
Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., Yagishita, N.,
Matsui, D., Koga, Y., Itoh, N., Kato, S., 1999. Fgf10 is essential for limb and lung
formation. Nat. Genet. 21, 138–141.
Snarr, B.S., O'Neal, J.L., Chintalapudi, M.R., Wirrig, E.E., Phelps, A.L., Kubalak, S.W.,
Wessels, A., 2007a. Isl1 expression at the venous pole identiﬁes a novel role for the
second heart ﬁeld in cardiac development. Circ. Res. 101, 971–974.
Snarr, B.S., Wirrig, E.E., Phelps, A.L., Trusk, T.C., Wessels, A., 2007b. A spatiotemporal
evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac
development. Dev. Dyn. 236, 1287–1294.
Snarr, B.S., Kern, C.B., Wessels, A., 2008. Origin and fate of cardiac mesenchyme. Dev.
Dyn. 237, 2804–2819.
Snider, P., Olaopa, M., Firulli, A.B., Conway, S.J., 2007. Cardiovascular development and
the colonizing cardiac neural crest lineage. ScientiﬁcWorldJournal 7, 1090–1113.
Song, L., Yan, W., Chen, X., Deng, C.X., Wang, Q., Jiao, K., 2007. Myocardial Smad4 is
essential for cardiogenesis in mouse embryos. Circ. Res. 101, 277–285.Stottmann, R.W., Choi, M., Mishina, Y., Meyers, E.N., Klingensmith, J., 2004. BMP
receptor IA is required in mammalian neural crest cells for development of the
cardiac outﬂow tract and ventricular myocardium. Development 131, 2205–2218.
Tekin, M., Öztürkmen Akay, H., Fitoz, S., Birnbaum, S., Cengiz, F.B., Sennaroglu, L.,
Incesulu, A., Yüksel Konuk, E.B., Hasanefendioglu Bayrak, A., Sentürk, S., Cebeci, I.,
Ütine, G.E., Tunçbilek, E., Nance, W.E., Duman, D., 2008. Homozygous FGF3
mutations result in congenital deafness with inner ear agenesis, microtia, and
microdontia. Clin. Genet. 73, 554–565.
Torlopp, A., Schlueter, J., Brand, T., 2010. Role of ﬁbroblast growth factor signaling
during proepicardium formation in the chick embryo. Dev. Dyn. 239, 2393–2403.
Urness, L.D., Paxton, C.N., Wang, X., Schoenwolf, G.C., Mansour, S.L., 2010. FGF signaling
regulates otic placode induction and reﬁnement by controlling both ectodermal
target genes and hindbrain Wnt8a. Dev. Biol. 340, 595–604.
van Wijk, B., van den Berg, G., Abu-Issa, R., Barnett, P., van der Velden, S., Schmidt, M.,
Ruijter, J.M., Kirby, M.L., Moorman, A.F., van den Hoff, M.J., 2009. Epicardium and
myocardium separate from a common precursor pool by crosstalk between bone
morphogenetic protein- and ﬁbroblast growth factor-signaling pathways. Circ. Res.
105, 431–441.
Vincent, S.D., Buckingham, M.E., 2010. How to make a heart: the origin and regulation
of cardiac progenitor cells. Curr. Top. Dev. Biol. 90, 1–41.
Vincentz, J.W., McWhirter, J.R., Murre, C., Baldini, A., Furuta, Y., 2005. Fgf15 is required
for proper morphogenesis of the mouse cardiac outﬂow tract. Genesis 41, 192–201.
Virágh, S., Challice, C.E., 1981. The origin of the epicardium and the embryonic
myocardial circulation in the mouse. Anat. Rec. 201, 157–168.
Vitelli, F., Taddei, I., Morishima, M., Meyers, E.N., Lindsay, E.A., Baldini, A., 2002. A
genetic link between Tbx1 and ﬁbroblast growth factor signaling. Development
129, 4605–4611.
Waldo, K.L., Kumiski, D., Kirby, M.L., 1996. Cardiac neural crest is essential for the
persistence rather than the formation of an arch artery. Dev. Dyn. 205, 281–292.
Ward, C., Stadt, H., Hutson, M., Kirby, M.L., 2005. Ablation of the secondary heart ﬁeld
leads to tetralogy of Fallot and pulmonary atresia. Dev. Biol. 284, 72–83.
Watanabe, Y., Miyagawa-Tomita, S., Vincent, S.D., Kelly, R.G., Moon, A.M., Buckingham,
M.E., 2010. Role of mesodermal FGF8 and FGF10 overlaps in the development
of the arterial pole of the heart and pharyngeal arch arteries. Circ. Res. 106, 495–503.
Wright, T.J., Mansour, S.L., 2003. Fgf3 and Fgf10 are required for mouse otic placode
induction. Development 130, 3379–3390.
Wright, T.J., Ladher, R., McWhirter, J., Murre, C., Schoenwolf, G.C., Mansour, S.L., 2004.
Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely
required for otic induction. Dev. Biol. 269, 264–275.
Xu, C., Liguori, G., Persico, M.G., Adamson, E.D., 1999. Abrogation of the Cripto gene in
mouse leads to failure of postgastrulation morphogenesis and lack of differenti-
ation of cardiomyocytes. Development 126, 483–494.
Yang, L., Cai, C.L., Lin, L., Qyang, Y., Chung, C., Monteiro, R.M., Mummery, C.L., Fishman,
G.I., Cogen, A., Evans, S., 2006. Isl1Cre reveals a common Bmp pathway in heart and
limb development. Development 133, 1575–1585.
Zhang, J., Lin, Y., Zhang, Y., Lan, Y., Lin, C., Moon, A.M., Schwartz, R.J., Martin, J.F., Wang,
F., 2008. Frs2α-deﬁciency in cardiac progenitors disrupts a subset of FGF signals
required for outﬂow tract morphogenesis. Development 135, 3611–3622.
Zhou, W., Lin, L., Majumdar, A., Li, X., Zhang, X., Liu, W., Etheridge, L., Shi, Y., Martin, J.,
Van de Ven, W., Kaartinen, V., Wynshaw-Boris, A., McMahon, A.P., Rosenfeld, M.G.,
Evans, S.M., 2007. Modulation of morphogenesis by noncanonical Wnt signaling
requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. Nat.
Genet. 39, 1225–1234.
